Insider Trading › KALV › Insiders
KALV
KALV·Insider activity
—
No end-of-day price on record
KALV
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
KALVS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, KALV insiders filed 0 purchases ($0) and 17 sales ($2.1M) on the open market, by 5 insiders. Newest filing May 29, 2026 (4 months ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by KALV insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$2.1MSales · 180 days
341Open-market transactions on record
5Insiders filing · 180 days
Purchases (code P) and sales (code S) of KALV common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
341 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −33.8K | $26.78 | $905K | 229.9Kdirect | May 27, 2026 | May 29, 2026 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −2,239 | $26.78 | $60K | 150.3Kdirect | May 26, 2026 | May 27, 2026 | Form 4 ↗ |
| Sweeny NicoleChief Commercial Officer | Sale | −1,489 | $26.78 | $40K | 59.3Kdirect | May 26, 2026 | May 27, 2026 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −1,966 | $26.78 | $53K | 229.9Kdirect | May 26, 2026 | May 27, 2026 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −2,685 | $26.78 | $72K | 147.5Kdirect | May 22, 2026 | May 26, 2026 | Form 4 ↗ |
| Sweeny NicoleChief Commercial Officer | Sale | −1,861 | $26.78 | $50K | 55.8Kdirect | May 22, 2026 | May 26, 2026 | Form 4 ↗ |
| Piekos BrianChief Financial Officer | Sale | −1,489 | $26.78 | $40K | 21.7Kdirect | May 22, 2026 | May 26, 2026 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −2,358 | $26.78 | $63K | 228.8Kdirect | May 22, 2026 | May 26, 2026 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −10.9K | $26.78 | $293K | 480.0Kdirect | May 22, 2026 | May 26, 2026 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −1,032 | $26.76 | $28K | 143.9Kdirect | May 18, 2026 | May 19, 2026 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −1,108 | $26.76 | $30K | 227.4Kdirect | May 18, 2026 | May 19, 2026 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −1,129 | $26.76 | $30K | 467.7Kdirect | May 18, 2026 | May 19, 2026 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −3,322 | $26.71 | $89K | 466.4Kdirect | May 12, 2026 | May 13, 2026 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −2,686 | $20.22 | $54K | 142.5Kdirect | Apr 17, 2026 | Apr 20, 2026 | Form 4 ↗ |
| Sweeny NicoleChief Commercial Officer | Sale | −1,862 | $20.22 | $38K | 51.4Kdirect | Apr 17, 2026 | Apr 20, 2026 | Form 4 ↗ |
| Piekos BrianChief Financial Officer | Sale | −1,862 | $20.22 | $38K | 18.1Kdirect | Apr 17, 2026 | Apr 20, 2026 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −9,550 | $20.22 | $193K | 462.6Kdirect | Apr 17, 2026 | Apr 20, 2026 | Form 4 ↗ |
| Venrock Healthcare Capital Partners EG, L.P.10% owner | Sale | −3,183 | $19.12 | $61K | 5.1Mindirect | Mar 26, 2026 | Mar 27, 2026 | Form 4 ↗ |
| Venrock Healthcare Capital Partners EG, L.P.10% owner | Sale | −15.4K | $18.82 | $290K | 5.1Mindirect | Mar 26, 2026 | Mar 27, 2026 | Form 4 ↗ |
| Venrock Healthcare Capital Partners EG, L.P.10% owner | Sale | −21.4K | $17.76 | $380K | 5.1Mindirect | Mar 26, 2026 | Mar 27, 2026 | Form 4 ↗ |
| Venrock Healthcare Capital Partners EG, L.P.10% owner | Sale | −160 | $17.53 | $3K | 5.1Mindirect | Mar 25, 2026 | Mar 27, 2026 | Form 4 ↗ |
| Venrock Healthcare Capital Partners EG, L.P.10% owner | Sale | −174.5K | $16.95 | $3.0M | 5.1Mindirect | Mar 25, 2026 | Mar 27, 2026 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −6,693 | $16.08 | $108K | 451.8Kdirect | Mar 9, 2026 | Mar 10, 2026 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −5,354 | $15.57 | $83K | 139.0Kdirect | Feb 23, 2026 | Feb 24, 2026 | Form 4 ↗ |
| Sweeny NicoleChief Commercial Officer | Sale | −3,975 | $15.57 | $62K | 47.0Kdirect | Feb 23, 2026 | Feb 24, 2026 | Form 4 ↗ |
| Piekos BrianChief Financial Officer | Sale | −1,767 | $15.57 | $28K | 13.8Kdirect | Feb 23, 2026 | Feb 24, 2026 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −4,347 | $15.57 | $68K | 226.7Kdirect | Feb 23, 2026 | Feb 24, 2026 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −10.0K | $15.57 | $156K | 442.9Kdirect | Feb 23, 2026 | Feb 24, 2026 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −1,163 | $15.00 | $17K | 133.1Kdirect | Feb 18, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −1,109 | $15.00 | $17K | 224.2Kdirect | Feb 18, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −1,038 | $15.00 | $16K | 429.7Kdirect | Feb 18, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −3,354 | $15.70 | $53K | 428.3Kdirect | Feb 12, 2026 | Feb 13, 2026 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −7,294 | $16.51 | $120K | 424.5Kdirect | Dec 8, 2025 | Dec 9, 2025 | Form 4 ↗ |
| Sweeny NicoleChief Commercial Officer | Sale | −3,813 | $13.45 | $51K | 39.7Kdirect | Nov 24, 2025 | Dec 4, 2025 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −5,296 | $13.45 | $71K | 131.8Kdirect | Nov 24, 2025 | Nov 26, 2025 | Form 4 ↗ |
| Piekos BrianChief Financial Officer | Sale | −4,471 | $13.45 | $60K | 10.5Kdirect | Nov 24, 2025 | Nov 26, 2025 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −4,331 | $13.45 | $58K | 223.5Kdirect | Nov 24, 2025 | Nov 26, 2025 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −10.9K | $13.45 | $147K | 416.2Kdirect | Nov 24, 2025 | Nov 26, 2025 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −3,075 | $14.48 | $45K | 125.9Kdirect | Nov 18, 2025 | Nov 19, 2025 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −2,683 | $14.48 | $39K | 133.6Kdirect | Nov 18, 2025 | Nov 19, 2025 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −4,466 | $14.48 | $65K | 403.9Kdirect | Nov 18, 2025 | Nov 19, 2025 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −3,328 | $11.55 | $38K | 399.0Kdirect | Nov 12, 2025 | Nov 13, 2025 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −7,294 | $15.84 | $116K | 395.2Kdirect | Sep 8, 2025 | Sep 9, 2025 | Form 4 ↗ |
| Sweeny NicoleChief Commercial Officer | Sale | −1,480 | $13.42 | $20K | 32.3Kdirect | Aug 25, 2025 | Aug 26, 2025 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −1,954 | $13.42 | $26K | 132.1Kdirect | Aug 25, 2025 | Aug 26, 2025 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −2,336 | $13.42 | $31K | 122.5Kdirect | Aug 25, 2025 | Aug 26, 2025 | Form 4 ↗ |
| Sweeny NicoleChief Commercial Officer | Sale | −1,864 | $13.22 | $25K | 28.8Kdirect | Aug 22, 2025 | Aug 25, 2025 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −2,362 | $13.22 | $31K | 130.9Kdirect | Aug 22, 2025 | Aug 25, 2025 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −10.9K | $13.22 | $145K | 386.9Kdirect | Aug 22, 2025 | Aug 25, 2025 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −2,942 | $13.22 | $39K | 119.8Kdirect | Aug 22, 2025 | Aug 25, 2025 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −2,649 | $13.19 | $35K | 129.5Kdirect | Aug 18, 2025 | Aug 19, 2025 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −2,939 | $13.19 | $39K | 116.5Kdirect | Aug 18, 2025 | Aug 19, 2025 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −4,409 | $13.19 | $58K | 374.5Kdirect | Aug 18, 2025 | Aug 19, 2025 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −33.0K | $15.69 | $517K | 369.6Kdirect | Jul 9, 2025 | Jul 10, 2025 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −30.3K | $15.69 | $475K | 127.9Kdirect | Jul 9, 2025 | Jul 10, 2025 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −7,169 | $14.50 | $104K | 315.1Kdirect | Jun 9, 2025 | Jun 10, 2025 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −2,146 | $11.31 | $24K | 113.0Kdirect | May 23, 2025 | May 27, 2025 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −1,926 | $11.31 | $22K | 98.2Kdirect | May 23, 2025 | May 27, 2025 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −2,689 | $11.88 | $32K | 110.2Kdirect | May 22, 2025 | May 23, 2025 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −2,317 | $11.88 | $28K | 97.0Kdirect | May 22, 2025 | May 23, 2025 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −9,999 | $11.88 | $119K | 306.6Kdirect | May 22, 2025 | May 23, 2025 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −2,600 | $11.84 | $31K | 95.6Kdirect | May 19, 2025 | May 20, 2025 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −3,808 | $11.84 | $45K | 293.4Kdirect | May 19, 2025 | May 20, 2025 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −2,776 | $11.84 | $33K | 106.6Kdirect | May 19, 2025 | May 20, 2025 | Form 4 ↗ |
| Venrock Healthcare Capital Partners EG, L.P.10% owner | Purchase | +25.0K | $9.42 | $236K | 5.3Mindirect | Apr 9, 2025 | Apr 11, 2025 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −6,669 | $11.97 | $80K | 287.8Kdirect | Mar 7, 2025 | Mar 10, 2025 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −2,394 | $10.02 | $24K | 102.9Kdirect | Feb 24, 2025 | Feb 25, 2025 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −1,918 | $10.02 | $19K | 94.0Kdirect | Feb 24, 2025 | Feb 25, 2025 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −2,601 | $9.82 | $26K | 92.7Kdirect | Feb 18, 2025 | Feb 19, 2025 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −3,125 | $9.82 | $31K | 100.3Kdirect | Feb 18, 2025 | Feb 19, 2025 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −5,104 | $9.82 | $50K | 278.9Kdirect | Feb 18, 2025 | Feb 19, 2025 | Form 4 ↗ |
| VHCP Management EG, LLC10% owner | Purchase | +61.7K | $9.33 | $576K | 5.3Mindirect | Feb 13, 2025 | Feb 14, 2025 | Form 4 ↗ |
| VHCP Management EG, LLC10% owner | Purchase | +100.0K | $9.23 | $923K | 5.2Mindirect | Feb 12, 2025 | Feb 14, 2025 | Form 4 ↗ |
| Venrock Healthcare Capital Partners III, L.P.10% owner | Purchase | +26.7K | $9.18 | $245K | 5.1Mindirect | Feb 11, 2025 | Feb 11, 2025 | Form 4 ↗ |
| Venrock Healthcare Capital Partners III, L.P.10% owner | Purchase | +4,137 | $9.14 | $38K | 5.1Mindirect | Feb 10, 2025 | Feb 11, 2025 | Form 4 ↗ |
| Venrock Healthcare Capital Partners III, L.P.10% owner | Purchase | +73.6K | $9.29 | $684K | 5.1Mindirect | Feb 7, 2025 | Feb 11, 2025 | Form 4 ↗ |
| VHCP Management III, LLC10% owner | Purchase | +14.6K | $9.22 | $134K | 5.0Mindirect | Feb 3, 2025 | Feb 3, 2025 | Form 4 ↗ |
| VHCP Management III, LLC10% owner | Purchase | +11.8K | $8.89 | $104K | 5.0Mindirect | Jan 31, 2025 | Feb 3, 2025 | Form 4 ↗ |
| VHCP Management III, LLC10% owner | Purchase | +43.7K | $8.76 | $383K | 5.0Mindirect | Jan 30, 2025 | Feb 3, 2025 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −7,627 | $9.75 | $74K | 274.6Kdirect | Dec 9, 2024 | Dec 9, 2024 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −2,187 | $9.87 | $22K | 97.0Kdirect | Nov 26, 2024 | Nov 27, 2024 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −1,963 | $9.87 | $19K | 91.1Kdirect | Nov 26, 2024 | Nov 27, 2024 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −14.4K | $9.26 | $133K | 266.6Kdirect | Nov 18, 2024 | Nov 19, 2024 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −7,192 | $9.26 | $67K | 90.0Kdirect | Nov 18, 2024 | Nov 19, 2024 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −8,077 | $9.26 | $75K | 94.2Kdirect | Nov 18, 2024 | Nov 19, 2024 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −7,352 | $12.19 | $90K | 250.8Kdirect | Sep 9, 2024 | Sep 10, 2024 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −2,135 | $12.40 | $26K | 83.7Kdirect | Aug 23, 2024 | Aug 26, 2024 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −1,916 | $12.40 | $24K | 85.7Kdirect | Aug 23, 2024 | Aug 26, 2024 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −7,973 | $12.01 | $96K | 80.9Kdirect | Aug 19, 2024 | Aug 21, 2024 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −14.2K | $12.01 | $171K | 242.5Kdirect | Aug 19, 2024 | Aug 21, 2024 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −7,102 | $12.01 | $85K | 84.5Kdirect | Aug 19, 2024 | Aug 21, 2024 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −7,465 | $11.53 | $86K | 224.5Kdirect | Jun 7, 2024 | Jun 10, 2024 | Form 4 ↗ |
| Feener Edward P.CHIEF SCIENTIFIC OFFICER | Sale | −8,088 | $11.76 | $95K | 72.9Kdirect | May 20, 2024 | May 21, 2024 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −13.2K | $11.76 | $155K | 70.3Kdirect | May 20, 2024 | May 21, 2024 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −22.0K | $11.76 | $258K | 216.4Kdirect | May 20, 2024 | May 21, 2024 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −11.6K | $11.76 | $137K | 80.1Kdirect | May 20, 2024 | May 21, 2024 | Form 4 ↗ |
| Feener Edward P.CHIEF SCIENTIFIC OFFICER | Sale | −300 | $14.72 | $4K | 62.2Kdirect | Feb 20, 2024 | Feb 21, 2024 | Form 4 ↗ |
| Feener Edward P.CHIEF SCIENTIFIC OFFICER | Sale | −19.6K | $14.04 | $275K | 62.5Kdirect | Feb 20, 2024 | Feb 21, 2024 | Form 4 ↗ |
| Feener Edward P.CHIEF SCIENTIFIC OFFICER | Sale | −8,397 | $14.11 | $118K | 82.0Kdirect | Feb 20, 2024 | Feb 21, 2024 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −12.1K | $14.11 | $170K | 72.9Kdirect | Feb 20, 2024 | Feb 21, 2024 | Form 4 ↗ |
| Palleiko Benjamin LCFO, CBO | Sale | −22.8K | $14.11 | $322K | 187.3Kdirect | Feb 20, 2024 | Feb 21, 2024 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −14.3K | $14.12 | $202K | 52.9Kdirect | Feb 20, 2024 | Feb 21, 2024 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −24.9K | $14.11 | $351K | 211.2Kdirect | Feb 20, 2024 | Feb 21, 2024 | Form 4 ↗ |
| Palleiko Benjamin LCFO, CBO | Sale | −40.9K | $15.01 | $613K | 159.1Kdirect | Feb 14, 2024 | Feb 16, 2024 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −58.4K | $15.01 | $876K | 181.7Kdirect | Feb 14, 2024 | Feb 16, 2024 | Form 4 ↗ |
| Feener Edward P.CHIEF SCIENTIFIC OFFICER | Sale | −28.2K | $15.01 | $423K | 71.7Kdirect | Feb 14, 2024 | Feb 16, 2024 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −39.9K | $15.01 | $599K | 66.2Kdirect | Feb 14, 2024 | Feb 16, 2024 | Form 4 ↗ |
| Shah Nimish P10% owner | Purchase | +29.7K | $14.70 | $437K | 4.8Mindirect | Feb 8, 2024 | Feb 8, 2024 | Form 4 ↗ |
| Shah Nimish P10% owner | Purchase | +51.8K | $14.56 | $755K | 4.8Mindirect | Feb 7, 2024 | Feb 8, 2024 | Form 4 ↗ |
| Shah Nimish P10% owner | Purchase | +4,474 | $14.74 | $66K | 4.7Mindirect | Feb 6, 2024 | Feb 8, 2024 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −700 | $16.81 | $12K | 117.5Kdirect | Feb 1, 2024 | Feb 5, 2024 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −9,300 | $16.18 | $150K | 118.2Kdirect | Feb 1, 2024 | Feb 5, 2024 | Form 4 ↗ |
| Venrock Healthcare Capital Partners III, L.P.10% owner | Purchase | +88.1K | $14.47 | $1.3M | 4.7Mindirect | Jan 30, 2024 | Feb 1, 2024 | Form 4 ↗ |
| Venrock Healthcare Capital Partners III, L.P.10% owner | Purchase | +80.6K | $14.22 | $1.1M | 4.7Mindirect | Jan 29, 2024 | Jan 29, 2024 | Form 4 ↗ |
| Venrock Healthcare Capital Partners III, L.P.10% owner | Purchase | +4,174 | $12.98 | $54K | 4.6Mindirect | Jan 26, 2024 | Jan 29, 2024 | Form 4 ↗ |
| Venrock Healthcare Capital Partners III, L.P.10% owner | Purchase | +7,030 | $12.73 | $89K | 4.6Mindirect | Jan 25, 2024 | Jan 29, 2024 | Form 4 ↗ |
| VHCP Management EG, LLC10% owner | Purchase | +20.7K | $12.44 | $257K | 4.6Mindirect | Jan 24, 2024 | Jan 24, 2024 | Form 4 ↗ |
| VHCP Management EG, LLC10% owner | Purchase | +10.9K | $12.54 | $137K | 4.5Mindirect | Jan 23, 2024 | Jan 24, 2024 | Form 4 ↗ |
| VHCP Management EG, LLC10% owner | Purchase | +67.5K | $12.55 | $848K | 4.5Mindirect | Jan 22, 2024 | Jan 24, 2024 | Form 4 ↗ |
| VHCP Co-Investment Holdings III, LLC10% owner | Purchase | +25.0K | $12.43 | $311K | 4.5Mindirect | Jan 19, 2024 | Jan 19, 2024 | Form 4 ↗ |
| VHCP Co-Investment Holdings III, LLC10% owner | Purchase | +39.7K | $12.51 | $496K | 4.4Mindirect | Jan 18, 2024 | Jan 19, 2024 | Form 4 ↗ |
| VHCP Co-Investment Holdings III, LLC10% owner | Purchase | +78.9K | $12.60 | $994K | 4.4Mindirect | Jan 17, 2024 | Jan 19, 2024 | Form 4 ↗ |
| Koh Bong Y10% owner | Purchase | +19.6K | $12.73 | $249K | 4.3Mindirect | Jan 16, 2024 | Jan 16, 2024 | Form 4 ↗ |
| Koh Bong Y10% owner | Purchase | +6,647 | $12.68 | $84K | 4.3Mindirect | Jan 11, 2024 | Jan 16, 2024 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −22.7K | $13.03 | $296K | 39.8Kdirect | Jan 11, 2024 | Jan 12, 2024 | Form 4 ↗ |
| Venrock Healthcare Capital Partners III, L.P.10% owner | Purchase | +47.7K | $12.67 | $604K | 4.3Mindirect | Jan 10, 2024 | Jan 10, 2024 | Form 4 ↗ |
| Venrock Healthcare Capital Partners III, L.P.10% owner | Purchase | +20.8K | $12.56 | $261K | 4.2Mindirect | Jan 9, 2024 | Jan 10, 2024 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −100 | $13.00 | $1K | 62.5Kdirect | Jan 9, 2024 | Jan 10, 2024 | Form 4 ↗ |
| Venrock Healthcare Capital Partners III, L.P.10% owner | Purchase | +69.2K | $12.44 | $861K | 4.2Mindirect | Jan 8, 2024 | Jan 10, 2024 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −17.2K | $13.01 | $224K | 62.6Kdirect | Jan 8, 2024 | Jan 10, 2024 | Form 4 ↗ |
| Shah Nimish P10% owner | Purchase | +41.8K | $12.11 | $506K | 4.2Mindirect | Jan 4, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Shah Nimish P10% owner | Purchase | +17.6K | $12.20 | $215K | 4.1Mindirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Koh Bong Y10% owner | Purchase | +6,013 | $12.49 | $75K | 4.1Mindirect | Dec 29, 2023 | Dec 29, 2023 | Form 4 ↗ |
| Koh Bong Y10% owner | Purchase | +471.5K | $12.50 | $5.9M | 4.1Mindirect | Dec 28, 2023 | Dec 29, 2023 | Form 4 ↗ |
| Koh Bong Y10% owner | Purchase | +41.5K | $11.97 | $497K | 3.6Mindirect | Dec 27, 2023 | Dec 29, 2023 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −30.0K | $12.02 | $361K | 127.5Kdirect | Dec 27, 2023 | Dec 28, 2023 | Form 4 ↗ |
| Audhya Paul K.Chief Medical Officer | Sale | −7,985 | $8.23 | $66K | 36.6Kdirect | Nov 20, 2023 | Nov 21, 2023 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −4,958 | $8.23 | $41K | 79.8Kdirect | Nov 20, 2023 | Nov 21, 2023 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −7,113 | $8.23 | $59K | 46.0Kdirect | Nov 20, 2023 | Nov 21, 2023 | Form 4 ↗ |
| Palleiko Benjamin LPresident, CFO, CBO & Sec'y | Sale | −13.0K | $8.23 | $107K | 112.4Kdirect | Nov 20, 2023 | Nov 21, 2023 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −14.8K | $8.23 | $122K | 157.5Kdirect | Nov 20, 2023 | Nov 21, 2023 | Form 4 ↗ |
| Cha AlbertDirector | Sale | −18.0K | $10.50 | $189K | 0direct | Sep 11, 2023 | Sep 13, 2023 | Form 4 ↗ |
| Audhya Paul K.Chief Medical Officer | Sale | −8,020 | $10.73 | $86K | 26.0Kdirect | Aug 18, 2023 | Aug 21, 2023 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −4,976 | $10.73 | $53K | 73.3Kdirect | Aug 18, 2023 | Aug 21, 2023 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −7,142 | $10.73 | $77K | 41.7Kdirect | Aug 18, 2023 | Aug 21, 2023 | Form 4 ↗ |
| Palleiko Benjamin LPresident, CFO, CBO & Sec'y | Sale | −13.1K | $10.73 | $140K | 95.3Kdirect | Aug 18, 2023 | Aug 21, 2023 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −14.9K | $10.73 | $160K | 146.8Kdirect | Aug 18, 2023 | Aug 21, 2023 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −2,604 | $10.14 | $26K | 37.3Kdirect | May 18, 2023 | May 19, 2023 | Form 4 ↗ |
| Palleiko Benjamin LPresident, CFO, CBO & Sec'y | Sale | −4,037 | $10.14 | $41K | 78.1Kdirect | May 18, 2023 | May 19, 2023 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −1,786 | $10.14 | $18K | 66.8Kdirect | May 18, 2023 | May 19, 2023 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −5,627 | $10.14 | $57K | 128.1Kdirect | May 18, 2023 | May 19, 2023 | Form 4 ↗ |
| Audhya Paul K.Chief Medical Officer | Sale | −2,780 | $10.14 | $28K | 13.0Kdirect | May 18, 2023 | May 19, 2023 | Form 4 ↗ |
| Audhya Paul K.Chief Medical Officer | Sale | −3,412 | $7.66 | $26K | 9,347direct | Feb 17, 2023 | Feb 23, 2023 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −2,228 | $7.66 | $17K | 64.4Kdirect | Feb 17, 2023 | Feb 23, 2023 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −2,727 | $7.66 | $21K | 35.7Kdirect | Feb 17, 2023 | Feb 23, 2023 | Form 4 ↗ |
| Palleiko Benjamin LPresident, CFO, CBO & Sec'y | Sale | −4,954 | $7.66 | $38K | 72.8Kdirect | Feb 17, 2023 | Feb 23, 2023 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −6,700 | $7.66 | $51K | 120.9Kdirect | Feb 17, 2023 | Feb 23, 2023 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −1,139 | $5.44 | $6K | 34.2Kdirect | Nov 18, 2022 | Nov 21, 2022 | Form 4 ↗ |
| Palleiko Benjamin LCFO, CBO & Secretary | Sale | −722 | $5.44 | $4K | 68.4Kdirect | Nov 18, 2022 | Nov 21, 2022 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −530 | $5.44 | $3K | 62.4Kdirect | Nov 18, 2022 | Nov 21, 2022 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −1,785 | $5.44 | $10K | 114.9Kdirect | Nov 18, 2022 | Nov 21, 2022 | Form 4 ↗ |
| Audhya Paul K.Chief Medical Officer | Sale | −722 | $5.44 | $4K | 5,946direct | Nov 18, 2022 | Nov 21, 2022 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −1,320 | $17.01 | $22K | 110.9Kdirect | Sep 2, 2022 | Sep 7, 2022 | Form 4 ↗ |
| Audhya Paul K.Chief Medical Officer | Sale | −725 | $14.96 | $11K | 1,693direct | Aug 17, 2022 | Aug 19, 2022 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −532 | $14.96 | $8K | 61.1Kdirect | Aug 17, 2022 | Aug 19, 2022 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −1,145 | $14.96 | $17K | 33.6Kdirect | Aug 17, 2022 | Aug 19, 2022 | Form 4 ↗ |
| Palleiko Benjamin LCFO, CBO & Secretary | Sale | −725 | $14.96 | $11K | 66.7Kdirect | Aug 17, 2022 | Aug 19, 2022 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −1,797 | $14.96 | $27K | 112.2Kdirect | Aug 17, 2022 | Aug 19, 2022 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −10.0K | $17.07 | $171K | 114.7Kdirect | Mar 9, 2022 | Mar 11, 2022 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −6,000 | $18.07 | $108K | 2,234direct | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −5,000 | $18.07 | $90K | 33.0Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −10.0K | $17.18 | $172K | 124.7Kdirect | Oct 1, 2021 | Oct 4, 2021 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −5,000 | $20.52 | $103K | 38.0Kdirect | Aug 2, 2021 | Aug 4, 2021 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −6,000 | $20.52 | $123K | 8,234direct | Aug 2, 2021 | Aug 4, 2021 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −5,650 | $24.35 | $138K | 134.7Kdirect | Jul 1, 2021 | Jul 2, 2021 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −4,350 | $23.88 | $104K | 140.3Kdirect | Jul 1, 2021 | Jul 2, 2021 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −1,067 | $30.04 | $32K | 144.7Kdirect | Jun 17, 2021 | Jun 22, 2021 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −8,933 | $30.05 | $268K | 145.7Kdirect | Jun 9, 2021 | Jun 11, 2021 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −1,062 | $27.05 | $29K | 14.2Kdirect | Jun 2, 2021 | Jun 3, 2021 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −7,138 | $26.33 | $188K | 15.3Kdirect | Jun 2, 2021 | Jun 3, 2021 | Form 4 ↗ |
| Smith Michael DavidSenior VP, Development | Sale | −7,500 | $26.83 | $201K | 0direct | Jun 1, 2021 | Jun 3, 2021 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −14 | $27.21 | $381 | 22.4Kdirect | Jun 1, 2021 | Jun 3, 2021 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −25.8K | $26.81 | $691K | 22.4Kdirect | Jun 1, 2021 | Jun 3, 2021 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale Amended | −6,000 | $24.84 | $149K | 48.2Kdirect | May 3, 2021 | May 7, 2021 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −5,000 | $24.84 | $124K | 43.0Kdirect | May 3, 2021 | May 6, 2021 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −6,000 | $24.84 | $149K | 54.2Kdirect | May 3, 2021 | May 6, 2021 | Form 4 ↗ |
| Maetzel AndreasSenior Vice President, Medical | Sale | −40.9K | $25.04 | $1.0M | 0direct | Apr 29, 2021 | Apr 29, 2021 | Form 4 ↗ |
| Smith Michael DavidSenior VP, Development | Sale | −10.0K | $25.76 | $258K | 0direct | Apr 28, 2021 | Apr 30, 2021 | Form 4 ↗ |
| Maetzel AndreasSenior Vice President, Medical | Sale | −507 | $25.65 | $13K | 0direct | Apr 28, 2021 | Apr 29, 2021 | Form 4 ↗ |
| Maetzel AndreasSenior Vice President, Medical | Sale | −10.0K | $25.54 | $255K | 507direct | Apr 28, 2021 | Apr 29, 2021 | Form 4 ↗ |
| Maetzel AndreasSenior Vice President, Medical | Sale | −15.0K | $25.25 | $379K | 10.5Kdirect | Apr 28, 2021 | Apr 29, 2021 | Form 4 ↗ |
| Maetzel AndreasSenior Vice President, Medical | Sale | −10.6K | $25.50 | $271K | 25.5Kdirect | Apr 28, 2021 | Apr 29, 2021 | Form 4 ↗ |
| Maetzel AndreasSenior Vice President, Medical | Sale | −11.0K | $25.79 | $284K | 0direct | Apr 27, 2021 | Apr 29, 2021 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −800 | $28.11 | $22K | 159.4Kdirect | Apr 1, 2021 | Apr 5, 2021 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −8,500 | $27.48 | $234K | 160.2Kdirect | Apr 1, 2021 | Apr 5, 2021 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −700 | $26.22 | $18K | 168.7Kdirect | Apr 1, 2021 | Apr 5, 2021 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −500 | $31.87 | $16K | 48.0Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −3,311 | $32.94 | $109K | 48.5Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −10.4K | $33.74 | $351K | 51.8Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −800 | $35.39 | $28K | 62.2Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Palleiko Benjamin LCFO, CBO & Secretary | Sale | −1,256 | $31.77 | $40K | 65.0Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Palleiko Benjamin LCFO, CBO & Secretary | Sale | −5,293 | $33.06 | $175K | 66.3Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Palleiko Benjamin LCFO, CBO & Secretary | Sale | −22.1K | $33.73 | $745K | 71.5Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Palleiko Benjamin LCFO, CBO & Secretary | Sale | −1,000 | $35.40 | $35K | 93.6Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −800 | $31.73 | $25K | 54.2Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −5,471 | $32.97 | $180K | 55.0Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −23.4K | $33.72 | $790K | 60.5Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −1,288 | $35.19 | $45K | 83.9Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −707 | $31.87 | $23K | 169.4Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −1,575 | $32.94 | $52K | 170.1Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −7,218 | $33.73 | $243K | 171.7Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −500 | $35.40 | $18K | 178.9Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −814 | $18.85 | $15K | 185.4Kdirect | Jan 4, 2021 | Jan 6, 2021 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −9,186 | $18.13 | $167K | 186.2Kdirect | Jan 4, 2021 | Jan 6, 2021 | Form 4 ↗ |
| Palleiko Benjamin LCFO, CBO & Secretary | Sale | −358 | $20.04 | $7K | 32.5Kdirect | Dec 30, 2020 | Jan 4, 2021 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −6,000 | $17.14 | $103K | 72.7Kdirect | Nov 2, 2020 | Nov 4, 2020 | Form 4 ↗ |
| Cha AlbertDirector | Purchase | +47.4K | $17.34 | $822K | 1.1Mindirect | Oct 30, 2020 | Nov 3, 2020 | Form 4 ↗ |
| Cha AlbertDirector | Purchase | +68.3K | $17.17 | $1.2M | 1.1Mindirect | Oct 30, 2020 | Nov 3, 2020 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −5,000 | $17.48 | $87K | 63.0Kdirect | Oct 29, 2020 | Nov 2, 2020 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −2,544 | $19.02 | $48K | 68.0Kdirect | Oct 21, 2020 | Oct 22, 2020 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −3,500 | $17.68 | $62K | 70.5Kdirect | Oct 21, 2020 | Oct 22, 2020 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −5,407 | $18.75 | $101K | 78.7Kdirect | Oct 21, 2020 | Oct 22, 2020 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −3,600 | $17.65 | $64K | 84.1Kdirect | Oct 21, 2020 | Oct 22, 2020 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −3,693 | $19.01 | $70K | 195.4Kdirect | Oct 21, 2020 | Oct 22, 2020 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −13.1K | $18.51 | $242K | 199.1Kdirect | Oct 21, 2020 | Oct 22, 2020 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −5,800 | $17.48 | $101K | 212.2Kdirect | Oct 21, 2020 | Oct 22, 2020 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −2,302 | $18.01 | $41K | 74.0Kdirect | Oct 20, 2020 | Oct 22, 2020 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −5,640 | $17.27 | $97K | 76.3Kdirect | Oct 20, 2020 | Oct 22, 2020 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −2,300 | $18.00 | $41K | 87.7Kdirect | Oct 20, 2020 | Oct 22, 2020 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −5,600 | $17.26 | $97K | 90.0Kdirect | Oct 20, 2020 | Oct 22, 2020 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −4,776 | $18.01 | $86K | 218.0Kdirect | Oct 20, 2020 | Oct 22, 2020 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −11.2K | $17.27 | $194K | 222.7Kdirect | Oct 20, 2020 | Oct 22, 2020 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −914 | $17.00 | $16K | 82.0Kdirect | Oct 16, 2020 | Oct 20, 2020 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −993 | $17.00 | $17K | 95.6Kdirect | Oct 16, 2020 | Oct 20, 2020 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −1,261 | $17.01 | $21K | 237.0Kdirect | Oct 16, 2020 | Oct 20, 2020 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −100 | $17.10 | $2K | 82.9Kdirect | Feb 5, 2020 | Feb 7, 2020 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −100 | $17.11 | $2K | 96.6Kdirect | Feb 5, 2020 | Feb 7, 2020 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −200 | $17.05 | $3K | 238.2Kdirect | Feb 5, 2020 | Feb 7, 2020 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −2,646 | $17.02 | $45K | 83.0Kdirect | Dec 20, 2019 | Dec 26, 2019 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −2,300 | $17.02 | $39K | 238.4Kdirect | Dec 20, 2019 | Dec 26, 2019 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −3,010 | $17.05 | $51K | 83.0Kdirect | Dec 16, 2019 | Dec 16, 2019 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −5,400 | $17.06 | $92K | 240.7Kdirect | Dec 16, 2019 | Dec 16, 2019 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −1,500 | $17.05 | $26K | 83.0Kdirect | Dec 13, 2019 | Dec 16, 2019 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −2,200 | $17.06 | $38K | 246.1Kdirect | Dec 13, 2019 | Dec 16, 2019 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −199 | $17.00 | $3K | 83.0Kdirect | Dec 12, 2019 | Dec 16, 2019 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −100 | $17.00 | $2K | 248.3Kdirect | Dec 12, 2019 | Dec 16, 2019 | Form 4 ↗ |
| SOLAND DANIEL BDirector | Purchase | +7,962 | $11.87 | $95K | 10.0Kdirect | Sep 27, 2019 | Sep 30, 2019 | Form 4 ↗ |
| SOLAND DANIEL BDirector | Purchase | +2,038 | $11.90 | $24K | 2,038direct | Sep 26, 2019 | Sep 30, 2019 | Form 4 ↗ |
| Cha AlbertDirector | Purchase | +5,137 | $17.13 | $88K | 124.6Kindirect | Jul 29, 2019 | Jul 30, 2019 | Form 4 ↗ |
| Cha AlbertDirector | Purchase | +24.7K | $17.13 | $424K | 1.0Mindirect | Jul 29, 2019 | Jul 30, 2019 | Form 4 ↗ |
| Cha AlbertDirector | Purchase | +21.9K | $16.83 | $369K | 997.8Kindirect | Jul 26, 2019 | Jul 30, 2019 | Form 4 ↗ |
| Cha AlbertDirector | Purchase | +4,558 | $16.83 | $77K | 119.4Kindirect | Jul 26, 2019 | Jul 30, 2019 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −1,900 | $18.65 | $35K | 96.7Kdirect | Jul 23, 2019 | Jul 24, 2019 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −7,355 | $18.35 | $135K | 83.0Kdirect | Jul 22, 2019 | Jul 24, 2019 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −1,400 | $18.57 | $26K | 98.6Kdirect | Jul 22, 2019 | Jul 24, 2019 | Form 4 ↗ |
| Cha AlbertDirector | Purchase | +49.7K | $17.84 | $886K | 975.8Kindirect | Jul 19, 2019 | Jul 19, 2019 | Form 4 ↗ |
| Cha AlbertDirector | Purchase | +10.3K | $17.68 | $182K | 114.9Kindirect | Jul 19, 2019 | Jul 19, 2019 | Form 4 ↗ |
| Cha AlbertDirector | Purchase | +220 | $16.93 | $4K | 104.6Kindirect | Jul 17, 2019 | Jul 19, 2019 | Form 4 ↗ |
| Cha AlbertDirector | Purchase | +1,060 | $16.97 | $18K | 926.1Kindirect | Jul 17, 2019 | Jul 19, 2019 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −10.0K | $17.04 | $170K | 248.5Kdirect | Jul 15, 2019 | Jul 17, 2019 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −1,000 | $26.79 | $27K | 83.0Kdirect | Apr 22, 2019 | Apr 23, 2019 | Form 4 ↗ |
| Yea ChristopherChief Development Officer | Sale | −6,355 | $25.92 | $165K | 84.0Kdirect | Apr 22, 2019 | Apr 23, 2019 | Form 4 ↗ |
| Palleiko Benjamin LCBO, CFO and Secretary | Sale | −2,000 | $25.80 | $52K | 32.5Kdirect | Apr 22, 2019 | Apr 22, 2019 | Form 4 ↗ |
| Palleiko Benjamin LCBO, CFO and Secretary | Sale | −1,073 | $25.51 | $27K | 32.5Kdirect | Apr 18, 2019 | Apr 22, 2019 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −916 | $25.39 | $23K | 100.0Kdirect | Apr 17, 2019 | Apr 18, 2019 | Form 4 ↗ |
| Feener Edward P.Chief Scientific Officer | Sale | −3,084 | $24.78 | $76K | 101.0Kdirect | Apr 17, 2019 | Apr 18, 2019 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −300 | $25.92 | $8K | 258.5Kdirect | Apr 15, 2019 | Apr 23, 2019 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −9,700 | $24.76 | $240K | 258.8Kdirect | Apr 15, 2019 | Apr 23, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV, L.P.10% owner | Sale | −374 | $29.40 | $11K | 47.5Kdirect | Apr 10, 2019 | Apr 10, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV, L.P.10% owner | Sale | −13.2K | $29.40 | $387K | 1.7Mdirect | Apr 10, 2019 | Apr 10, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV, L.P.10% owner | Sale | −377 | $28.53 | $11K | 47.8Kdirect | Apr 9, 2019 | Apr 10, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV, L.P.10% owner | Sale | −13.3K | $28.53 | $379K | 1.7Mdirect | Apr 9, 2019 | Apr 10, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV, L.P.10% owner | Sale | −629 | $29.49 | $19K | 48.2Kdirect | Apr 8, 2019 | Apr 10, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV, L.P.10% owner | Sale | −22.2K | $29.49 | $654K | 1.7Mdirect | Apr 8, 2019 | Apr 10, 2019 | Form 4 ↗ |
| Maetzel AndreasSenior Vice President Medical | Sale | −5,000 | $30.00 | $150K | 0direct | Apr 5, 2019 | Apr 9, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −253 | $28.76 | $7K | 48.9Kdirect | Apr 2, 2019 | Apr 2, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −8,888 | $28.76 | $256K | 1.7Mdirect | Apr 2, 2019 | Apr 2, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −1,458 | $27.66 | $40K | 49.1Kdirect | Apr 1, 2019 | Apr 2, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −51.4K | $27.66 | $1.4M | 1.7Mdirect | Apr 1, 2019 | Apr 2, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −969 | $28.40 | $28K | 50.6Kdirect | Mar 29, 2019 | Apr 2, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −34.1K | $28.40 | $969K | 1.8Mdirect | Mar 29, 2019 | Apr 2, 2019 | Form 4 ↗ |
| SV Life Sciences Fund IV (GP), L.P.10% owner | Sale | −1,012 | $27.80 | $28K | 51.5Kdirect | Mar 28, 2019 | Mar 28, 2019 | Form 4 ↗ |
| SV Life Sciences Fund IV (GP), L.P.10% owner | Sale | −35.7K | $27.80 | $991K | 1.8Mdirect | Mar 28, 2019 | Mar 28, 2019 | Form 4 ↗ |
| SV Life Sciences Fund IV (GP), L.P.10% owner | Sale | −1,599 | $29.06 | $46K | 52.5Kdirect | Mar 27, 2019 | Mar 28, 2019 | Form 4 ↗ |
| SV Life Sciences Fund IV (GP), L.P.10% owner | Sale | −56.3K | $29.06 | $1.6M | 1.9Mdirect | Mar 27, 2019 | Mar 28, 2019 | Form 4 ↗ |
| SV Life Sciences Fund IV (GP), L.P.10% owner | Sale | −831 | $29.70 | $25K | 54.1Kdirect | Mar 26, 2019 | Mar 28, 2019 | Form 4 ↗ |
| SV Life Sciences Fund IV (GP), L.P.10% owner | Sale | −29.3K | $29.70 | $869K | 1.9Mdirect | Mar 26, 2019 | Mar 28, 2019 | Form 4 ↗ |
| Koh Bong Y10% owner | Sale | −500.0K | $28.75 | $14.4M | 1.5Mindirect | Mar 18, 2019 | Mar 20, 2019 | Form 4 ↗ |
| SVLSF IV, LLC10% owner | Sale | −7,246 | $26.70 | $193K | 55.0Kdirect | Mar 18, 2019 | Mar 20, 2019 | Form 4 ↗ |
| SVLSF IV, LLC10% owner | Sale | −255.2K | $26.70 | $6.8M | 1.9Mdirect | Mar 18, 2019 | Mar 20, 2019 | Form 4 ↗ |
| Crockett Thomas AndrewCEO · Director | Sale | −3,000 | $30.16 | $90K | 268.5Kdirect | Mar 14, 2019 | Mar 15, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −893 | $23.04 | $21K | 62.2Kdirect | Mar 5, 2019 | Mar 6, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −31.4K | $23.04 | $724K | 2.2Mdirect | Mar 5, 2019 | Mar 6, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −1,197 | $22.91 | $27K | 63.1Kdirect | Mar 4, 2019 | Mar 6, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −42.2K | $22.91 | $966K | 2.2Mdirect | Mar 4, 2019 | Mar 6, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −4,764 | $20.60 | $98K | 64.3Kdirect | Feb 21, 2019 | Feb 21, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −167.8K | $20.60 | $3.5M | 2.3Mdirect | Feb 21, 2019 | Feb 21, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −641 | $20.02 | $13K | 69.1Kdirect | Feb 20, 2019 | Feb 21, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −22.6K | $20.02 | $452K | 2.4Mdirect | Feb 20, 2019 | Feb 21, 2019 | Form 4 ↗ |
| SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.10% owner | Sale | −508 | $20.73 | $11K | 69.7Kdirect | Feb 19, 2019 | Feb 21, 2019 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →